In diabetic foot infections antibiotics are to treat infection, not to heal wounds

被引:137
作者
Abbas, Mohamed [1 ]
Uckay, Ilker [1 ]
Lipsky, Benjamin A. [1 ,2 ]
机构
[1] Univ Geneva, Geneva Univ Hosp & Med Sch, Infect Dis Serv, CH-1211 Geneva 14, Switzerland
[2] Univ Oxford, Div Med Sci, Oxford, England
关键词
antibiotic therapy; diabetic foot; foot infection; foot ulcer; topical antimicrobials; wound healing; RESISTANT STAPHYLOCOCCUS-AUREUS; LOWER-EXTREMITY INFECTIONS; SKIN-STRUCTURE INFECTIONS; COMPLICATED SKIN; OPEN-LABEL; ANTIMICROBIAL THERAPY; OSTEOMYELITIS; MULTICENTER; MANAGEMENT; EFFICACY;
D O I
10.1517/14656566.2015.1021780
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
Introduction: Diabetic foot ulcers, especially when they become infected, are a leading cause of morbidity and may lead to severe consequences, such as amputation. Optimal treatment of these diabetic foot problems usually requires a multidisciplinary approach, typically including wound debridement, pressure off-loading, glycemic control, surgical interventions and occasionally other adjunctive measures. Areas covered: Antibiotic therapy is required for most clinically infected wounds, but not for uninfected ulcers. Unfortunately, clinicians often prescribe antibiotics when they are not indicated, and even when indicated the regimen is frequently broader spectrum than needed and given for longer than necessary. Many agents are available for intravenous, oral or topical therapy, but no single antibiotic or combination is optimal. Overuse of antibiotics has negative effects for the patient, the health care system and society. Unnecessary antibiotic therapy further promotes the problem of antibiotic resistance. Expert opinion: The rationale for prescribing topical, oral or parenteral antibiotics for patients with a diabetic foot wound is to treat clinically evident infection. Available published evidence suggests that there is no reason to prescribe antibiotic therapy for an uninfected foot wound as either prophylaxis against infection or in the hope that it will hasten healing of the wound.
引用
收藏
页码:821 / 832
页数:12
相关论文
共 104 条
[1]
Conservative management of diabetic foot osteomyelitis [J].
Acharya, S. ;
Soliman, M. ;
Egun, A. ;
Rajbhandari, S. M. .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2013, 101 (03) :E18-E20
[2]
Effect of Daptomycin on Local Interleukin-6, Matrix Metalloproteinase-9, and Metallopeptidase Inhibitor 1 in Patients With MRSA-Infected Diabetic Foot [J].
Ambrosch, Andreas ;
Halevy, Daniel ;
Fwity, Boushra ;
Brin, Thomas ;
Lobmann, Ralf .
INTERNATIONAL JOURNAL OF LOWER EXTREMITY WOUNDS, 2014, 13 (01) :12-16
[3]
Mini-review: Lactoferrin: a bioinspired, anti-biofilm therapeutic [J].
Ammons, M. C. ;
Copie, V. .
BIOFOULING, 2013, 29 (04) :443-455
[4]
Aragon-Sanchez J, 2014, INT J LOW EXTREM WOU
[5]
Antibiotic Misuse A Global Crisis [J].
Bell, Michael .
JAMA INTERNAL MEDICINE, 2014, 174 (12) :1920-1921
[6]
Predicting the pathogen of diabetic toe osteomyelitis by two consecutive ulcer cultures with bone contact [J].
Bernard, L. ;
Assal, M. ;
Garzoni, C. ;
Uckay, I. .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2011, 30 (02) :279-281
[7]
Moxifloxacin in Complicated Skin and Skin Structure Infections (cSSSIs): A Prospective, International, Non-Interventional, Observational Study [J].
Bogner, Johannes R. ;
Kutaiman, Ammar ;
Esguerra-Alcalen, Melanie ;
Heldner, Stephanie ;
Arvis, Pierre .
ADVANCES IN THERAPY, 2013, 30 (06) :630-643
[8]
Larval therapy:: A novel treatment in eliminating methicillin-resistant Staphylococcus aureus from diabetic foot ulcers [J].
Bowling, Frank L. ;
Salgami, Eleanna V. ;
Boulton, Andrew J. M. .
DIABETES CARE, 2007, 30 (02) :370-371
[9]
Browne A C, 2001, Ostomy Wound Manage, V47, P44
[10]
Chantelau E, 1996, DIABETIC MED, V13, P156, DOI 10.1002/(SICI)1096-9136(199602)13:2<156::AID-DIA59>3.0.CO